Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid growth of abnormal myeloid cells, which are responsible for producing red blood cells, white blood cells, and platelets.
AML is a serious and aggressive form of leukemia that can progress rapidly if left untreated. It primarily affects adults, although it can occur in children as well. The exact cause of AML is unknown, but certain risk factors such as exposure to radiation, certain chemicals, or previous chemotherapy treatment may increase the likelihood of developing the disease.
Symptoms of AML can vary but often include fatigue, shortness of breath, frequent infections, easy bruising or bleeding, and bone pain. These symptoms occur due to the overcrowding of abnormal cells in the bone marrow, which hinders the production of healthy blood cells.
Diagnosis of AML involves a series of tests, including blood tests, bone marrow biopsy, and genetic analysis. These tests help determine the type of leukemia, its severity, and guide treatment decisions.
Treatment for AML typically involves chemotherapy, which aims to destroy the abnormal cells and allow the bone marrow to produce healthy blood cells again. In some cases, a stem cell transplant may be necessary to replace the diseased bone marrow with healthy stem cells.
Prognosis for AML varies depending on factors such as age, overall health, and genetic abnormalities. While AML can be challenging to treat, advancements in medical research have improved survival rates in recent years.
In summary, acute myelogenous leukemia (AML) is a type of cancer that affects the bone marrow and blood. It is a serious and aggressive disease that requires prompt diagnosis and treatment. If you or someone you know is experiencing symptoms associated with AML, it is important to seek medical attention for proper evaluation and care.